SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sabbadini, M G
Right arrow Articles by Passaleva, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabbadini, M G
Right arrow Articles by Passaleva, A
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Brain Diseases
*Lupus
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations

M G Sabbadini

University of Milano, Milano, Italy; HS Raffaele Scientific Institute, Milano, Italy; Divisione di Medicina Seconda, HS Raffaele, Via Olgettina 60, 20132, Milano, Italy

A A Manfredi

E Bozzolo

L Ferrario

HS Raffaele Scientific Institute, Milano, Italy

C Rugarli

University of Milano, Milano, Italy; HS Raffaele Scientific Institute, Milano, Italy

R Scorza

University of Milano, Milano, Italy; Scientific Institute H Maggiore, Milano, Italy

L Origgi

M Vanoli

Scientific Institute H Maggiore, Milano, Italy

O Gambini

L Vanzulli

D Croce

HS Raffaele Scientific Institute, Milano, Italy

A Campana

Biomedical Sciences Institute, HS Paolo, University Department of Mental Health, Milano, Italy

C Messa

F Fazio

University of Milano, Milano, Italy; HS Raffaele Scientific Institute, Milano, Italy

A Tincani

G Anzola

R Cattaneo

A Padovani

R Gasparotti

Spedali Civili and University of Brescia, Brescia, Italy

R Gerli

R Quartesan

M Piccirilli

University of Perugia, Perugia, Italy

A Farsi

E Emmi

M Domeneghetti

C Piccini

L Massacesi

A Pupi

M De Cristoforis

University of Firenze, Firenze, Italy

M Danieli

M Candela

P Fraticelli

M Bartolini

U Salvolini

G Danieli

University of Ancona, Ancona, Italy

A Passaleva

University of Firenze, Firenze, Italy

Objective: To verify whether features of CNS involvement can be detected in SLE patients without overt neuropsychiatric manifestations.

Methods: 114 SLE patients who had never received a diagnosis of neuropsychiatric lupus (never NPSLE) were studied and compared to 65 SLE patients with known neuropsychiatric involvement (NPSLE). The study relied on evaluation of neurocognitive functions by means of a battery of neuropsychological tests, on psychiatric and neuropsychological assessments and on neuroimaging studies (computed tomography, magnetic resonance, single photon emission computed tomography (SPECT)).

Results: Clinical features, including disease duration/activity and pharmacological therapy, of never-NPSLE and NPSLE patients were similar. Short-term and long-term memory, visuo-spatial and verbal information processing were similarly compromised in never-NPSLE and in NPSLE patients; only attention was significantly more compromised in NPSLE patients. Psychiatric morbidity was higher than expected in never-NPSLE patients, although less than in the control neuropsychiatric group. Ischemic lesions, multiple small high intensity lesions and cortical atrophy, detected by CT and MR scans, as well as abnormal SPECT were also frequently detected in never NPSLE patients. Interestingly, left parietal and occipital area hypoperfusion by SPECT was significantly more frequent in the patients with impaired visuo-spatial intelligence and short-term memory.

Conclusions: Most abnormalities detected by available diagnostic tools and characteristics of neuropsychiatric SLE are also present in non-symptomatic patients. They may derive from an unexpected widespread involvement of the CNS and are not per se sufficient, in the absence of clinical manifestations, for a diagnosis of neuropsychiatric SLE.

Key Words: systemic lupus erythematosus • central nervous system • SPECT • neurocognitive functions

Lupus, Vol. 8, No. 1, 11-19 (1999)
DOI: 10.1191/096120399678847344


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
D Paran, I Litinsky, I Shapira-Lichter, S Navon, T Hendler, D Caspi, and E Vakil
Impaired memory and learning abilities in patients with systemic lupus erythematosus as measured by the Rey Auditory Verbal Learning Test
Ann Rheum Dis, June 1, 2009; 68(6): 812 - 816.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
H Tatsukawa, K Ishii, M Haranaka, M Kumagi, I Hino, and H Yoshimatsu
Evaluation of average amount of cerebral blood flow measured by brain perfusion index in patients with neuropsychiatric systemic lupus erythematosus.
Lupus, June 1, 2005; 14(6): 445 - 449.
[Abstract] [PDF]


Home page
LupusHome page
E Kozora, M C Ellison, J A Waxmonsky, F S Wamboldt, and T L Patterson
Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus
Lupus, May 1, 2005; 14(5): 363 - 372.
[Abstract] [PDF]


Home page
NeurologyHome page
E. Y. McLaurin, S. L. Holliday, P. Williams, and R. L. Brey
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus
Neurology, January 25, 2005; 64(2): 297 - 303.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
O Nived, G Sturfelt, M H Liang, and P De Pablo
The ACR nomenclature for CNS lupus revisited
Lupus, December 1, 2003; 12(12): 872 - 876.
[Abstract] [PDF]


Home page
LupusHome page
S D Denburg and J A Denburg
Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus
Lupus, December 1, 2003; 12(12): 883 - 890.
[Abstract] [PDF]


Home page
LupusHome page
S L Holliday, M G Navarrete, D Hermosillo-Romo, C R Valdez, A R Saklad, A Escalante, and R L Brey
Validating a computerized neuropsychological test battery for mixed ethnic lupus patients
Lupus, September 1, 2003; 12(9): 697 - 703.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Oku, T. Atsumi, S. Furukawa, T. Horita, Y. Sakai, S. Jodo, Y. Amasaki, K. Ichikawa, O. Amengual, and T. Koike
Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement
Rheumatology, June 1, 2003; 42(6): 773 - 777.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Jonsen, A. A. Bengtsson, O. Nived, B. Ryberg, and G. Sturfelt
Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality
Rheumatology, November 1, 2002; 41(11): 1308 - 1312.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
L. V. C. Portela, J. C. T. Brenol, R. Walz, M. Bianchin, A. B. L. Tort, U. P. Canabarro, S. Beheregaray, J. A. Marasca, R. M. Xavier, E. C. Neto, et al.
Serum S100B Levels in Patients with Lupus Erythematosus: Preliminary Observation
Clin. Vaccine Immunol., January 1, 2002; 9(1): 164 - 166.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Mathieu, G Sanna, A Mameli, C Pinna, A Vacca, A Cauli, G Passiu, and M Piga
Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus
Lupus, January 1, 2002; 11(1): 52 - 56.
[Abstract] [PDF]


Home page
LupusHome page
G Sanna, M Piga, J W Terryberry, M T Peltz, S Giagheddu, L Satta, A Ahmed, A Cauli, C Montaldo, G Passiu, et al.
Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations
Lupus, October 1, 2000; 9(8): 573 - 583.
[Abstract] [PDF]


Home page
LupusHome page
R Hilker, A Thiel, C Geisen, and J Rudolf
Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome
Lupus, May 1, 2000; 9(4): 311 - 316.
[Abstract] [PDF]



Advertisement